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High performance magneto-
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Rustem Zairov1,2, Asiya Mustafina1,2, Nataliya Shamsutdinova1,2, Irek Nizameev1,3, 
Beatriz Moreira4, Svetlana Sudakova1, Sergey Podyachev1, Alfia Fattakhova2, 
Gulnara Safina4,5, Ingemar Lundstrom6,7, Aidar Gubaidullin1 & Alberto Vomiero6
Polyelectrolyte-coated nanoparticles consisting of terbium and gadolinium complexes with calix[4]
arene tetra-diketone ligand were first synthesized. The antenna effect of the ligand on Tb(III) green 
luminescence and the presence of water molecules in the coordination sphere of Gd(III) bring strong 
luminescent and magnetic performance to the core-shell nanoparticles. The size and the core-shell 
morphology of the colloids were studied using transmission electron microscopy and dynamic light 
scattering. The correlation between photophysical and magnetic properties of the nanoparticles and 
their core composition was highlighted. The core composition was optimized for the longitudinal 
relaxivity to be greater than that of the commercial magnetic resonance imaging (MRI) contrast agents 
together with high level of Tb(III)-centered luminescence. The tuning of both magnetic and luminescent 
output of nanoparticles is obtained via the simple variation of lanthanide chelates concentrations in the 
initial synthetic solution. The exposure of the pheochromocytoma 12 (PC 12) tumor cells and periphery 
human blood lymphocytes to nanoparticles results in negligible effect on cell viability, decreased 
platelet aggregation and bright coloring, indicating the nanoparticles as promising candidates for dual 
magneto-fluorescent bioimaging.
Noninvasive diagnostics provides in situ insight to the structural and functional features of the investigated sys-
tems and organs. The use of magnetic and optical techniques is emerging for these purposes. Improved sensing 
in tissues, which in turn can differentiate normal tissue from diseased one, can be achieved by using magnetic 
contrast agents (CA)1–4 and optical emissive probes5–9. The f-elements (rare earth elements) are outstanding can-
didates for this, since their chelates combine unique magnetic and luminescent characteristics3,10,11.
It is well known that trivalent lanthanide chelates are very good alternatives to organic luminescent stains 
or quantum dots in view of their extraordinary properties. Their emission bands span both the visible and near 
infrared (NIR) ranges and can be easily discriminated from the organic background by both emission wavelength 
and photoluminescence lifetime. They possess enhanced photostability, larger Stokes shift and longer excited state 
lifetime over conventional organic fluorophores11,12.
Typically, all lanthanide luminescent labels contain an organic chromophore, which serves as antenna or sen-
sitizer to absorb the excitation light and to transfer this energy to the emission levels of lanthanide ions. This 
antenna acts as a shield for the lanthanide ion from the solvent quenching effects as well as a reactive group for 
coupling the chelate complex to biotargets12,13.
1A. E. Arbuzov Institute of Organic and Physical Chemistry, Kazan Scientific Center of Russian Academy of Sciences, 
Arbuzov str., 8, 420088, Kazan, Russia. 2Kazan (Volga region) Federal university, Kremlyovskaya str., 18, 420008, 
Kazan, Russia. 3Kazan National Research Technological University, K. Marks str., 68, 420015, Kazan, Russia. 
4Department of Chemistry and Molecular Biology, University of Gothenburg, Kemigården4, 412 96 Gothenburg, 
Sweden. 5Division of Biological Physics, Department of Physics, Chalmers University of Technology, Kemigården1, 
412 96 Gothenburg, Sweden. 6Division of Materials Science, Department of Engineering Sciences and Mathematics, 
Luleå University of Technology, SE-97187 Luleå, Sweden. 7Department of Physics, Chemistry and Biology, Linköping 
University, 581 83 Linköping, Sweden. Correspondence and requests for materials should be addressed to R.Z. 
(email: rustem02@yandex.ru)
Received: 02 September 2016
accepted: 06 December 2016
Published: 16 January 2017
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 7:40486 | DOI: 10.1038/srep40486
Having seven unpaired electrons at the valence shell, gadolinium in the form of chelates provides high posi-
tive contrast between healthy and tumor tissues14. Despite the proven clinical efficacy of Gd-DTPA, Gd-DOTA 
and other gadolinium-based molecular MRI agents, they suffer from dechelation and transmetallation processes 
taking place in the presence of chelating anions and endogenous cations, correspondingly15,16. At the same time, 
luminescent function of lanthanide-containing optical labels is quenched in presence of organic background in 
the biological sample due to antennae-ligands replacement11,17,18.
Nanoparticulate approach has attracted increasing interest in recent years13,19–22. Novel MRI CA based on 
gadolinium-containing nanoparticles show enhanced relaxation parameters compared to commercial speci-
mens13,23–26. The slowed down rotation of magnetic ions is the main reason for better relaxivity of the nanopar-
ticulate CA versus mononuclear gadolinium complexes. Enhanced permeation, retention, lowered toxicity of 
nanoparticulate CA contribute to the enhanced positive imaging, as well27–29.
Large number of attempts to combine the benefits of simultaneous magnetic and luminescent properties of 
lanthanides(III) were undertaken on oxide30–33, fluoride34–37 and phosphate38–40 matrices, targeting the devel-
opment of multimodal imaging materials. However, the development of novel nanoparticulate platforms with 
possibility to conjoin efficient magnetic and optical performance of lanthanides is still a challenge.
The precipitation of lanthanide complexes from water miscible organic solvents to polyelectrolyte-containing 
water solutions under effective stirring is an example of easy and effective synthetic pathway to embed large 
amount of lanthanide functional complexes to the nanoparticle. The synthesis of europium-doped luminescent 
polyelectrolyte colloids was first described by Mustafina et al.41 and later applied to various terbium42, and gado-
linium43 complexes.
Herein we report for the first time the synthesis and characterization of polystyrenesulfonate-coated nanopar-
ticles consisting of terbium and gadolinium complexes with calix[4]arene tetra-diketone ligand. The new nano-
particles are rationally designed to simultaneously exhibit the optical properties of Tb and the magnetic behavior 
of Gd ions, towards bifunctional system with strong luminescence and high relaxivity. Colloidal, photophysical 
and magnetic studies were performed on nanoparticles with varying core composition, which is controlled by 
changing the Tb:Gd atomic ratio. We compared the relaxation parameters of the produced nanoparticles with 
commercial MRI agents. Particular attention was paid to the simplicity and universality of the strategy for the 
synthesis of bifunctional species. Tuning both magnetic and luminescent output of nanoparticles is possible via 
simple variation of composition of initial synthetic solution of lanthanides chelates. This synthetic strategy opens 
the door to new biomedical applications of lanthanide complexes.
Results and Discussion
Nanoparticle morphology. We synthesized polyelectrolyte-coated nanoparticles consisting of terbium(III) 
and gadolinium(III) complexes with calix[4]arene tetra-diketone ligand 1 (Fig. 1) according to the procedure 
described in the experimental section. According to our previous reports, the complex formation of 1 with both 
Gd(III)43 and Tb(III)44 occurs in 1:1 stoichiometry in alkaline DMF solutions. Our previous report43 on the syn-
thesis of PSS-stabilized Gd-1 colloids demonstrated the ability of keeping the full amount of Gd-1 complex within 
NP shell, thanks to the poor solubility of the complex, experimentally confirmed by luminescence measurements 
of the supernatant solutions in the synthesis of PSS-stabilized Tb-1 colloids. This tendency provides great syn-
thetic advantage, since the Tb-to-Gd ratio in the colloids can be easily driven by their ratio in the organic (DMF) 
solution. Transmission electron microscopy (TEM) and dynamic light scattering (DLS) techniques were applied 
to examine the morphology of the fabricated colloids. The aliquot of as-prepared colloidal solution was diluted 
ten times by deionized water to adjust the concentration of Ln(III) ions in the colloidal form to 0.075 mM to 
perform the DLS study.
The DLS measurements reveal hydrodynamic diameter being 100–170 nm in the obtained colloids (Table 1). 
These values are similar to those previously reported for other polyelectrolyte-coated lanthanide chelates17,42. 
Their size distribution is narrow even without any prefiltration or fractionizing, which is clearly seen from the 
polydispersity (PDI) indices. Moreover, the sizes are stable during the period of one week at least.
The molar ratio of Ln (Tb or Gd) in the core of Ln-1 based colloids was calculated via equation (1):
χ = +C /(C C ) (1)Gd Gd Gd Tb
where CGd and CTb are the concentrations of the lanthanide chelates.
DLS and electrokinetic potential measurements confirm hard core-soft shell morphology of the colloids 
(Table 1), where the high negative charge of PSS-based exterior layer is the reason for their high colloidal stability. 
The DLS data reveal the size of hydrated PSS-coated colloids, while their functionality results from the hard cores 
inside the polyelectrolyte coating17,43,45. The previously published reports17,43 highlight hard-soft morphology of 
the colloids. The TEM image of the dried colloids presented in Fig. 1g confirms the hard-soft nature of the col-
loids, where soft polyelectrolyte shell is evident from grey color spheres, while denser lanthanide-based cores can 
be clearly defined from the darker shade of grey color. The nanoparticle diameters are in the range 27–37 nm and 
the polyelectrolyte shell thickness is 2–3 nm. Sizes revealed from the TEM images of the dried aqueous colloids 
(Fig. 1g) are lower than those estimated by DLS measurements, because of their aggregation and  swelling of 
polyelectrolyte coating in aqueous solutions. Moreover, the hard templates within the soft PSS coating are not 
uniform, consisting of smaller (2–10 nm sized) cores, as previously reported for PSS-stabilized Gd-1 colloids43. 
The TEM images of PSS-stabilized Tb-1 colloids confirm similar morphology (Fig. 1h). Figure 1i schematically 
illustrates the core-shell morphology of PSS-coated Gd-1/Tb-1 nanoparticle.
The size distribution of PSS-stabilized Gd-1/Tb-1 colloids at various Gd content from the TEM data (Fig. S1 
in SI) revealed no detectable effect of the Gd content on their size. The uniformity of both Gd- and Tb-based col-
loids is fully consistent with the isomorphism of Tb-1 and Gd-1 complexes. It is worth noting that the previously 
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reported amorphous nature of the hard templates of PSS-stabilized Gd-1 colloids results from metastability of 
the hard cores, probably due to reprecipitation of the complex from organic to aqueous solutions43. Similar XRD 
measurements (for detailed description of the procedure see SI) were performed here for PSS-stabilized Tb-1 
colloids. Both diffraction pattern and two-dimensional diffraction picture (Fig. 2) confirm the amorphous nature 
of the hard cores of the core-shell colloids. Moreover, XRD measurements of the ligand 1 (5,11,17,23-tetrakis 
[(acetylaceton-3-yl)methyl)]-25,26,27,28-tetrahydroxy-calix[4]arene) also indicate its amorphous nature (Fig. S2 
in SI).
Luminescence properties. It is known that the intraconfigurational 4f–4 f transitions are formally for-
bidden, and thus possess very low molar absorptivities, limiting direct excitation of lanthanide-centered emis-
sion. Complexation with a sensitizing chromophore (referred as the antenna) allows overcoming this restriction, 
Figure 1. Structure of 5,11,17,23-tetrakis[(acetylaceton-3-yl)methyl)]-25,26,27,28-tetrahydroxy-calix[4]arene 
1 (a) and possible coordination modes of Ln-1 in the alkalized DMF solution (b–f). For more details see ref. 44. 
TEM image of dried PSS-coated Gd-1 colloids (g), higher resolution TEM image of the same colloids (h), and 
schematic illustration of PSS-coated Gd-1/Tb-1 nanoparticle and interactions on its core surface with water 
molecules and UV light (i).
χGd Diameter (nm) PDI ζ (mV)
0 113.6 ± 1.6 0.168 − 29.9 ± 0.1
0.2 106.4 ± 2.0 0.153 − 32.6 ± 0.2
0.4 144.4 ± 3.4 0.354 − 31.9 ± 0.2
0.6 166.4 ± 2.8 0.238 − 33.1 ± 0.2
0.8 123.5 ± 2.2 0.168 − 28.3 ± 0.1
1 101.8 ± 1.7 0.180 − 29.5 ± 0.1
Table 1.  The hydrodynamic diameter, electrokinetic potential (ζ) and polydispersity indices (PDI) 
of PSS-covered polyelectrolyte nanoparticles as a function of Gd content (χGd = 1, 0.8, 0.6, 0.4, 0.2, 0; 
χTb = 1 − χGd).
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providing indirect excitation of Ln(III) emission levels via energy transfer from singlet and triplet levels of 
organic ligand. 1,3-Diketones have been reported as a very promising antenna-ligands for the Ln(III)-centered 
emission46–48. The luminescent properties of Tb-1 have recently been discussed44.
The Ln-1 aqueous colloids with various χ Tb exhibit emission under excitation at 320 nm with the spectrum 
patterns 5D4 → 7F6 (494 nm), 5D4 → 7F5 (545 nm), 5D4 → 7F4 (587 nm) peculiar for Tb(III)-centered luminescence 
(Fig. S3 in SI). The intensity of the main emission at 546 nm coming from the 5D4–7F5 transition is applied for the 
quantitative evaluation of the change of luminescence intensity under the variation of χ Tb. The gradual increase 
of luminescence intensity with increase of number of Tb emission centers in the core of nanoparticles is expected. 
This trend is observed when χ Tb increases from 0.2 to 0.6, while it is less pronounced when χ Tb increases from 0.6 
to 1.0 (Table 2). The time resolved luminescence measurements were performed in PSS-stabilized Tb-1/Gd-1 col-
loids at various χ Tb. The decay curves of Tb(III)-centered luminescence (Figs S4–S8 in SI) are well fitted by a biex-
ponential decay. Monoexponential decay results in poorer fitting parameters. The obtained excited state lifetime 
values shown in Table 2 point to the presence of Tb(III)-containing species with longer (τ 1 = 0.271–0.296 ms) 
and shorter (τ 2 = 0.066–0.072 ms) values. The origin of the double τ values most probably arises from chelated 
and dechelated forms of Tb(III) species within PSS-stabilized Tb-1/Gd-1 nanoparticles. Taking into account 
the size of PSS-stabilized Tb-1/Gd-1 nanoparticles (Fig. 1) a dechelation of Tb(III) complexes at the interface 
is the most probable reason for the origin of the dechelated Tb(III) forms. The higher τ 1 values tend to remain 
unchanged with the χ Tb increase from 0.2 to 0.6, while gradually decrease with the increase in χ Tb from 0.6 to 
1.0, while the smaller τ 2 values remain almost constant (Table 2). It is also worth noting that τ 1 and lumines-
cence intensity present opposite trends as a function of χ Tb. The decreased intensity as a function of increas-
ing χ Tb can be explained by the concentration-induced quenching of Tb(III)-centered luminescence49,50. The 
concentration-induced quenching occurs when the distance between emission centers is small enough for effi-
cient cross relaxation (5D3:7F6) → (5D4:7F0) between two neighboring Tb(III) ions51.
The above-mentioned amorphous nature of PSS-stabilized Ln-1 colloids (Fig. 2) confirms the dense pack-
ing of lanthanide centers within hard cores of the colloids. The obtained results reveal the optimal composition 
(χ Tb = 0.4) of PSS-stabilized Tb-1/Gd-1 nanoparticles for the best combination of steady state intensity and 
excited state lifetime values.
Magnetic properties. Longitudinal and transverse relaxation times T1 and T2 of water molecule protons 
in the presence of studied paramagnetic Gd(III)-containing colloids were registered at 20 MHz magnetic field 
frequency (Tables S1–S6 in SI). The 1/T1 and 1/T2 plots versus Gd(III) concentration of PSS-stabilized Tb-1/
Gd-1 aqueous colloids at various χ Gd are presented in Fig. 3a,b and Table 2. The corresponding longitudinal and 
transverse relaxivities (r1 and r2) of PSS-stabilized Ln-1 nanoparticles were calculated as a tangent of plots’ incline 
angle at 1/T1(2) vs CGd coordinates and presented in Fig. 3c as a function of χ Gd.
Figure 2. X-ray diffraction pattern of the PSS-stabilized Tb-1 colloids. Two-dimensional X-ray diffraction 
picture (inset).
χTb χGd I (a.u.) τ1 (ms) τ2 (ms) r1 r2
1 0 5609000 0.271 ± 0.005 0.072 ± 0.002 — —
0.8 0.2 4567000 0.277 ± 0.004 0.066 ± 0.002 13,46 17,17
0.6 0.4 4918000 0.284 ± 0.004 0.067 ± 0.002 10,67 12,72
0.4 0.6 5204000 0.296 ± 0.006 0.072 ± 0.003 7,62 9,02
0.2 0.8 2585000 0.291 ± 0.005 0.066 ± 0.002 8,15 9,36
0 1 3000 — 6,83 7,86
Table 2.  Luminescence intensities (I), excited state lifetimes (τ), as well as r1 and r2 of PSS-stabilized Ln-1 
(Ln = Tb, Gd) nanoparticles at various χTb and χGd.
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It is worth noting that r1 and r2 values keep almost constant, when χ Gd decreases from 1.0 to 0.6. The further 
decrease in χ Gd from 0.6 to 0.2 results in the increase of r1 and r2 (Fig. 3c). The explanation of this tendency should 
be preceded by discussing on main mechanisms contributing to relaxation of water protons at the colloid/water 
interface. Albeit no theoretical framework is known for accurate interpretation of relaxivities in Gd(III)-based 
colloids, several mechanisms are proposed as predominantly contributing to enhancing water protons relaxivity 
in Gd(III)-based aqueous colloids. Slow rotation resulting from inclusion of mononuclear Gd(III) complexes into 
nanoparticles should be claimed as the main reason for high relaxivity in Gd(III)-based aqueous colloids. This 
factor is guided by size of the hard cores inside the polyelectrolyte coating. Taking into account that exchange 
between inner-sphere and bulk water molecules is another key factor affecting relaxivity of Gd(III)-based col-
loids, size-dependent ratio of Gd(III)-centers localized close to the surface to those localized inside the hard cores 
is also worth noting. The size of the hard cores inside the PSS-coating varies from 2 to 10 nm for PSS-stabilized 
Gd-1 colloids43. According to TEM results, the size of the colloids is not greatly affected by the change in χ Gd, 
although no exact assignment of the smaller versus larger nanoparticles within the polyelectrolyte coating to Tb-1 
or Gd-1 complex, as well as their mixture, can be done. The increase in r1 and r2 for χ Gd from 0.6 to 0.2 points to 
predominant localization of Gd(III) centers close to the colloid/water interface at low χ Gd values. The reasons for 
this behavior are not clear, and further investigations are ongoing.
The luminescence intensities (I) of PSS-stabilized Ln-1 colloids were plotted in Fig. 3c together with the r1 
and r2 values versus χ Gd in order to show the correlation between the property and the composition of the col-
loids. Dashed rectangle shows the optimal χ Gd in the colloids core exhibiting the best magnetic and luminescent 
parameters.
Taking into account that both molecular and nanoparticulate (PSS-stabilized colloids) forms of Tb-1 suffer 
from different radiationless decay mechanisms, it is interesting to evaluate the ratio of luminescence intensity 
measured in aqueous PSS-stabilized colloids of Tb-1 (INP) to that in DMF solution of Tb-1 (IMOL) at the same 
complex concentration (0.75 mM). The measured spectra (Fig. S9 in SI) point to the stronger luminescence inten-
sity of the colloids versus the complex in solution. The ratio INP/IMOL is equal to 1.7 ± 0.2, which argues in favor of 
application of PSS-stabilized Tb-1 colloids versus Tb-1 complexes as contrast agents in bioimaging.
Effect of the colloids on cell viability and platelets aggregation. The toxic effect of PSS-stabilized 
Tb-1 and Gd-1 colloids on human blood lymphocytes and pheochromocytoma (PC12) cells were determined 
by means of MTT assay (based on tetrazolium dye MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) and trypan blue viability test, respectively. The obtained results indicate no toxic effect of the colloids on 
human blood lymphocytes at 32 μ g/mL of PSS-coated Gd-1 colloids and 66 μ g/mL of PSS-coated Tb-1 colloids 
(Fig. 4a). Both 50 μ g/mL and 500 μ g/mL of Tb-1 colloids show no negative effect on PC12 cell viability. The num-
ber of viable cells was calculated as 99.4% and 97.7%, respectively.
Effect of the colloids on platelet aggregation is of great importance for their biomedical applicability due to 
the risk of formation of blood clots. The effect of the colloids on platelet aggregation was determined in the 200 μ l 
mixture of 50 μ l of platelets mass in Hanks balanced salt solution (HBSS), and 150 μ l of PBS (0.1 M, pH 7.2) in 
the presence of PSS-stabilized Ln-1 colloids. The values in Fig. 4b indicate the decrease in the rates of platelet 
aggregation after the admixture with the colloids. The obtained results indicate low thrombogenic potential of 
PSS-stabilized Tb-1 colloids, which along with their low cytotoxicity effect point to potential applicability of the 
colloids in bioimaging.
Interaction of colloids with cells using fluorescent microscopy. A cellular uptake behavior of lumi-
nescent nanoparticles is affected by several factors, including size, exterior charge and aggregation of nanoparti-
cles in physiological media52,53. Taking into account high negative electrokinetic potential values of PSS-stabilized 
colloids (Table 1), very poor, if any, cellular uptake behavior of the nanoparticles is anticipated due to weak 
Figure 3. 1/T1 (a) and 1/T2 (b) of PSS-stabilized Ln-1 nanoparticles with various χ Gd: 1.0 (1), 0.8 (2), 0.6 (3), 
0.4 (4), 0.2 (5) versus Gd(III) concentration. Straight lines are linear fitting of the experimental data. Relaxivity 
values r1 (1-blue) and r2 (2-purple), luminescence intensities (3-red) of PSS-stabilized Ln-1 colloids versus χ Gd 
(с). Dashed rectangle reflects the optimal χ Gd in the colloids core exhibiting the best magnetic and luminescent 
parameters.
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interaction of negatively charged nanoparticles with cellular membrane. Nevertheless, interactions of the nan-
oparticles with inorganic and biological background in physiological media can affect the localization of nan-
oparticles on cell membrane. Thus, DLS measurements were performed for the aqueous colloids in PBS buffer 
before and after the protein admixture, since protein corona is well documented factor, affecting both aggregation 
and cellular uptake behavior of nanoparticles54,55. The size increase from ∼ 100 to ∼ 500 nm (Table 1 and S7 in SI) 
is observed from DLS measurements of PSS-stabilized Tb-1 colloids in water and in PBS buffer (0.1 M). This 
tendency indicates that the exterior charge neutralization resulted from the binding with counterions. Aqueous 
buffer solutions of bovine serum albumin (BSA), which was applied as a model protein, are characterized by 
10–11 nm aggregates (Table S7 in SI). The admixture of BSA (1 g·L−1) to PSS-stabilized colloids in the buffer 
solutions results in the size decrease to ∼ 400 nm, although this trend can be explained by the contribution of the 
smaller aggregates of BSA.
Figure 5 illustrates bright field and confocal fluorescent images of rat PC12 cells after their exposure for 
2 hours at 37 °C to PSS-stabilized Tb-1 colloids. The images indicate predominant localization of the emissive 
nanoparticles at the cellular membrane, although some cellular uptake cannot be excluded. It is worth noting that 
cellular uptake behavior can be enhanced by the recharging of the exterior layer of PSS-stabilized Tb-1 colloids, 
which will be done in the nearest future, although the represented results highlight a potential of PSS-stabilized 
Tb-1 colloids as a basis for imaging applications.
Conclusions
Core-shell morphology nanoparticles with terbium and gadolinium complexes with calix[4]arene tetra-diketone 
ligand (1) as hard core and polystyrenesulfonate coating as soft shell as promising basis for magneto-luminescent 
imaging are introduced for the first time. Water dispersed polyelectrolyte-stabilized Ln-1 nanoparticles exhibit 
high colloidal stability. Their size is about 30 nm in the dried state, increasing to about 100 nm in aqueous solutions 
due to hydration effect. Luminescent and magnetic relaxation properties of the colloids are greatly dependent on 
Gd-1:Tb-1 ratio. The latter can be easily tuned for best bifunctional magneto-luminescent performance by simple 
mixing of Tb(III) and Gd(III) complexes in the initial DMF solution at the desired ratio. Both of Ln-1 colloids 
are improved by appropriate variation of Gd-1:Tb-1 ratio. The optimized composition (Gd-1:Tb-1 = 0.2/0.8) of 
the colloids for optimal Tb(III)-centered luminescence and Gd(III)-based relaxivity results in better performance 
than the commercial Gd(III)-contrast agents. The low cytotoxicity and thrombogenic potential of PSS-stabilized 
Tb-1 colloids open the door for their application in biomarking. Confocal microscopy imaging reveals predomi-
nant localization of the emissive nanoparticles at the cellular membrane, which is in agreement with the negative 
exterior charge of PSS-stabilized Tb-1 colloids.
Experimental section
Reagents and materials. Gadolinium nitrate Gd(NO3)3·6H2O (99.9%) (Alfa Aesar), terbium nitrate 
hydrate (Tb(NO3)3∙5H2O) (Alfa Aesar) triethylamine (TEA) (Acros Organics), poly(sodium 4-styrenesulfonate) 
(PSS) (MWaverage = 70000) (Acros Organics), sodium chloride (Sigma-Aldrich), were used as commercially 
received without further purification. N,N-Dimethylformamide (DMF) (Acros Organics) was twice distilled over 
P2O5.
Synthesis of 5,11,17,23-tetrakis[(acetylaceton-3-yl)methyl)]-25,26,27,28-tetrahydroxy-calix[4]arene was 
reported previously43.
Figure 4. (a) Cell viability of periphery human blood lymphocytes without (1) and in the presence of 32 μ g/mL 
of PSS-coated Gd-1 (2), and 66 μ g/mL of Tb-1 (3) nanoparticles; PC 12 tumor cells (4) in the presence of  
50 μ g/mL of PSS-coated Tb-1 colloids (5) and 500 μ g/mL of PSS-coated Tb-1 colloids (6). (b) Platelet 
aggregation in the presence of 10 μ M adrenaline (1), 86 μ g/mL PSS-coated Gd-1 (3), and 193 μ g/mL PSS-coated 
Tb-1 (4) nanoparticles and without any additives (2) as a per cent of absorptivity changes at 540 nm after 5 min.
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Synthesis of colloids. The colloids were synthesized via precipitation of water non-soluble lanthanide(III) 
complexes from DMF solution to polyelectrolyte containing aqueous solution. Four equivalents of triethylam-
monia (TEA) additives (C = 18 mM) to DMF solution of 4.5 mMcalix[4]arene 1 were followed by lanthanide(III) 
(C = 4.5 mM) addition to promote the formation of 1:1 complex between lanthanide(III) cations and anions of 1. 
The aliquote of 1 ml DMF dissolved lanthanide(III) complex was added to the 5 ml of polystyrenesulfonate sul-
fonate aqueous solution (1 g·L−1) in the presence of NaCl (C = 0.5 M)at the effective stirring (2200 rpm) drop-
wisely using the syringe pump. The solution becomes turbid since the dispersion of polyelectrolyte stabilized 
nanoprecipitate forms. The obtained colloids were washed from the DMF and excess amounts of PSS and NaCl 
via triple centrifugation (11000 rpm, 10 min.)/decantation and redispergation (deionized water addition and 
ultrasonication for 30 min.) procedures.
Six syntheses were performed from DMF solutions with different Gd/Tb molar ratios (χ Gd = 0, 0.2, 0.4, 0.6, 
0.8 and 1) within the core of polyelectrolyte coated colloids. Two equimolar solutions of Gd-1 and Tb-1 in DMF 
were prepared (C = 4.5 mM) for this purpose. The Gd/Tb core composition was varied via volume of aliquots of 
Gd-1 and Tb-1 in initial DMF solution. The colloids were ultrasonicated for 30 min before measurements. All 
measurements have been performed in triplicates.
Methods of characterization of colloids. DLS measurements were performed using Malvern Mastersize 
2000 particle analyzer operating with a He–Ne laser (633 nm) and emitting vertically polarized light as a light 
source. The transmission electron microscopy (TEM) images have been obtained with Hitachi HT7700, Japan. 
Samples have been sonicated in water for 30 min and then dispersed on 200 mesh copper grids with continuous 
formvar support films. The images have been acquired at an accelerating voltage of 100 kV.
The steady-state luminescence and time-resolved spectra have been recorded on a spectrofluorometer FL3–
221-NIR (Jobin Yvon). Excitation of samples has been performed at 320 nm, and emission detected at 545 nm 
with 1 nm slit width for both excitation and emission.
Bruker “Minispec mq20” NMR analyzer was employed to measure T1 and T2 of water molecule protons in 
studied solutions at 20 MHz magnetic field. Inversion-recovery and Carr-Purcell-Meiboom-Gill (CPMG) pulse 
sequences56 were used for longitudinal T1 and transverse T2 relaxation times accordingly with 20 points data 
collected for fitting57.
Powder X-ray diffraction (PXRD) measurements were performed on a Bruker D8 Advance diffractometer 
equipped with Vario attachment and Vantec linear PSD, using Cu radiation (40 kV, 40 mA) monochromated by 
the curved Johansson monochromator (λ Cu Kα1 1.5406 Å). Room-temperature data were collected in the reflec-
tion mode with a flat-plate sample. The samples were loaded on a standard zero diffraction silicon plate, which 
was kept spinning (15 rpm) throughout the data collection. Patterns were recorded in the 2Θ range between 3° 
and 60°, in 0.008° steps, with a step time of 0.1–4.0 s. Several diffraction patterns in various experimental modes 
were collected and summed for the sample. Processing of the obtained data performed using EVA58 software 
packages. Additional experiments were carried out on a single-crystal X-ray diffractometer Bruker Smart Apex 
II CCD using Mo radiation (MoKα, graphite monochromator, λ 0.71073 Å) at the 23 °С with the liquid samples 
in a standard glass 1 mm capillary. ССD-detector of the diffractometer was kept on the fixed values of 2θ angles 
(0° and 30°), recording time was varied from 30 to 400 seconds. Standard powder diffractograms were obtained by 
integration of several two-dimension scattering patterns with the use of software packages APEX259.
Cell viability test. Cell viability of human blood lymphocytes towards nanoparticles was estimated using 
MTT proliferative test (Promega, USA). Yellow MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenil-tetrazolium 
bromide) turns into purple formazan under the effect of mitochondrial NADN reductase of living cells. After the 
lysis of the cells formazan dissolves in the DMSO. The activity of the mitochondrial reductase (and cell viability 
respectively) has been defined as the function of the formazan absorbance (500–600 nm).
Human blood lymphocytes (7500 cells per well) were cultivated in 100 μ l of DMEM in the presence of nano-
particles under the standard conditions in a 96-well cultural plate during 3.5 hours. Cells were washed using PSB 
Figure 5. Images of PC 12 tumor cells: optical (a); confocal in the presence of PSS-coated Tb-1 nanoparticles 
(b); colored rework of b using GFP emission filter (510–550 nm) (c), λ ex = 360–370 nm. Scale bar indicates 20 um.
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(phosphate-buffered saline (PBS; 10 mM/L; pH 7.2) and the mixture of 80 μ l of DMEM and 20 μ l of nanoparti-
cles was added. Then the 20 μ l aliquot of 5 mg/ml MTT was added to each well and incubated in CO2-incubator 
under the 37 °C for 3.5 hours. The medium was removed then and 150 μ l of DMSO were added. The absorbance 
of the resulted solutions was measured at 590 nm after 10 minutes using plate spectrophotometer Stat Fax 2100 
(Awareness Technology, USA).
The effect of NPs on viability of PC12 cells was assessed by the trypan blue exclusion test. All NPs samples 
were sonicated for 30 min prior the experiment. Solutions of NPs were prepared by diluting the stock solution of 
NPs in cell growth media and adjusting to pH 7.4. Cells were seeded in flasks and, after confluence was reached, 
they were exposed for 2 h with 0 (control), 50 μ g/mL and 500 μ g/mL of Tb-1 colloids. Conditions of exposure 
were 5% CO2, 37 °C, 100% humidity. Thereafter, cells were trypsinized, by standard trypsinization, and resus-
pended in equal volumes of culture medium and trypan. Viable (unstained) and nonviable (blue-stained) cells 
were counted using a haemocytometer, and cell viability was calculated as (N viable cells/N total cells) × 100%.
Platelets aggregation. The citrated human blood was centrifuged at 120·g for 15 min at room temperature 
to obtain platelets mass containing 25·107 of platelets per ml. Platelets concentration was determined with auto-
matic hematology analyzer Abacus (Diatron, Austria) according to the manufacturer method.
The platelets aggregation was detected in a 200 μ l mixture of 50 μ l of platelets mass in HBSS (125·105 of platelets), 
50 μ l of 0.188 mM/L water dispersion of nanoparticles and 100 μ l of PBS (0.1 M, pH 7.2). Platelet aggregation was 
recorded after 5 min.
Positive control 200 μ l mixture contained 50 μ l of platelets mass in HBSS, adrenaline (10 μ M, Sigma) and 100 μ l 
of PBS (0.1 M, pH 7.2).
The spontaneous platelets aggregation was examined in a 200 μ l mixture of 50 μ l of platelets mass in HBSS, 
and 150 μ l of PBS (0.1 M, pH 7.2). The absorbance of the resulted solutions at 540 nm was measured using spec-
trophotometer Shimadzu (Japan) at 37 °C. The extent of aggregation was calculated quantitatively as a percentage 
of the maximal change in optical density.
The authors confirm that all methods were carried out in accordance with relevant guidelines and regulations. 
A Kazan Federal university committee approved all experimental protocols. Informed consent was obtained from 
all volunteers. There are no animal experiments included in the project.
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